Novel allergen-independent immunotherapy: positive data from a phase Ila pilot study with CpG contained in virus-like particles by Bull, C, Muller, P, Renner, W, Bachmann, M, Kundig, T, Senti, G

A double-blind, placebo-controlled phase IIa study investigating CYT003-QbG10 as a novel allergen-independent immunotherapy in patients suffering from grass pollen allergy by Senti, G, Bull, C, Mueller, P, Ulrich, M, Bachmann, M, Renner, W, Kuendig, T

Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. by Senti, G, Johansen, P, Haug, S, Bull, C, Gottschaller, C, Müller, P, Pfister, T, Maurer, P, Bachmann, M, Graf, N, Kündig, T

Room-temperature type-II multiferroic phase induced by pressure in cupric oxide by Terada, N, Khalyavin, D, Manuel, P, Orlandi, F, Ridley, C, Bull, C, Ono, R, Solovyev, I, Prabhakaran, D, Boothroyd, A

Evaluation of offspring size-number invariants in 12 species of lizard. by Uller, T, While, G, Wapstra, E, Warner, D, Goodman, B, Schwarzkopf, L, Langkilde, T, Doughty, P, Radder, R, Rohr, D, Bull, C, Shine, R, Olsson, M

Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer by Malla, SB, Byrne, RM, Lafarge, MW, Corry, SM, Fisher, NC, Tsantoulis, PK, Mills, ML, Ridgway, RA, Lannagan, TRM, Najumudeen, AK, Gilroy, KL, Amirkhah, R, Maguire, SL, Mulholland, EJ, Belnoue-Davis, HL, Grassi, E, Viviani, M, Rogan, E, Redmond, KL, Sakhnevych, S, McCooey, AJ, Bull, C, Hoey, E, Sinevici, N, Domingo, E, Blake, A, Maughan, TS, Leedham, SJ, Koelzer, VH